|
| | Rosiglitazone hydrochloride Basic information |
| Product Name: | Rosiglitazone hydrochloride | | Synonyms: | ROSIGLITAZONE HYDROCHLORIDE 99%;5-[4-[2-[N-Methyl-N- (pyridinyl) amino]ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride;Rosiglitazone hydrochloride;Rosiglitazone hydroc;5-(4-(2-(Methyl(pyridin-2-yl)aMino)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride;5-[(4-{2-[Methyl(pyridin-2-yl)aMino]ethoxy}phenyl)Methyl]-1,3-thiazolidine-2,4-dione hydrochloride;5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, hydrochloride (1:1);BRL-49653 HCl | | CAS: | 302543-62-0 | | MF: | C18H20ClN3O3S | | MW: | 393.89 | | EINECS: | 1308068-626-2 | | Product Categories: | Inhibitors;API;Inhibitor | | Mol File: | 302543-62-0.mol |  |
| | Rosiglitazone hydrochloride Chemical Properties |
| storage temp. | Store at -20°C | | solubility | ≥39.4 mg/mL in DMSO; ≥2.81 mg/mL in H2O with gentle warming and ultrasonic; ≥51.2 mg/mL in EtOH with ultrasonic | | form | solid | | CAS DataBase Reference | 302543-62-0(CAS DataBase Reference) |
| | Rosiglitazone hydrochloride Usage And Synthesis |
| Chemical Properties | Rosiglitazone is a hypoglycemic drug developed by GS, and the revalent compounds are disclosed in European Patent EP 306228. | | Uses | Rosiglitazone hydrochloride has better stability than rosiglitazone maleate, and is very suitable for application in the manufacture of common pharmaceutical preparations. It is a thiazolidinedione antidiabetic drug, which can effectively control blood sugar by improving insulin sensitivity. | | Biological Activity | rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the ppar receptors in fat cells. | | target | |
| | Rosiglitazone hydrochloride Preparation Products And Raw materials |
|
